Literature DB >> 15627218

Dent Disease with mutations in OCRL1.

Richard R Hoopes1, Antony E Shrimpton, Stephen J Knohl, Paul Hueber, Bernd Hoppe, Janos Matyus, Ari Simckes, Velibor Tasic, Burkhard Toenshoff, Sharon F Suchy, Robert L Nussbaum, Steven J Scheinman.   

Abstract

Dent disease is an X-linked renal proximal tubulopathy associated with mutations in the chloride channel gene CLCN5. Lowe syndrome, a multisystem disease characterized by renal tubulopathy, congenital cataracts, and mental retardation, is associated with mutations in the gene OCRL1, which encodes a phosphatidylinositol 4,5-bisphosphate (PIP(2)) 5-phosphatase. Genetic heterogeneity has been suspected in Dent disease, but no other gene for Dent disease has been reported. We studied male probands in 13 families, all of whom met strict criteria for Dent disease but lacked mutations in CLCN5. Linkage analysis in the one large family localized the gene to a candidate region at Xq25-Xq27.1. Sequencing of candidate genes revealed a mutation in the OCRL1 gene. Of the 13 families studied, OCRL1 mutations were found in 5. PIP(2) 5-phosphatase activity was markedly reduced in skin fibroblasts cultured from the probands of these five families, and protein expression, measured by western blotting, was reduced or absent. Slit-lamp examinations performed in childhood or adulthood for all five probands showed normal results. Unlike patients with typical Lowe syndrome, none of these patients had metabolic acidosis. Three of the five probands had mild mental retardation, whereas two had no developmental delay or behavioral disturbance. These findings demonstrate that mutations in OCRL1 can occur with the isolated renal phenotype of Dent disease in patients lacking the cataracts, renal tubular acidosis, and neurological abnormalities that are characteristic of Lowe syndrome. This observation confirms genetic heterogeneity in Dent disease and demonstrates more-extensive phenotypic heterogeneity in Lowe syndrome than was previously appreciated. It establishes that the diagnostic criteria for disorders resulting from mutations in the Lowe syndrome gene OCRL1 need to be revised.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15627218      PMCID: PMC1196371          DOI: 10.1086/427887

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  22 in total

Review 1.  Endocytic traffic in polarized epithelial cells: role of the actin and microtubule cytoskeleton.

Authors:  G Apodaca
Journal:  Traffic       Date:  2001-03       Impact factor: 6.215

2.  ClC-5 Cl- -channel disruption impairs endocytosis in a mouse model for Dent's disease.

Authors:  N Piwon; W Günther; M Schwake; M R Bösl; T J Jentsch
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

3.  Ocrl1, a PtdIns(4,5)P(2) 5-phosphatase, is localized to the trans-Golgi network of fibroblasts and epithelial cells.

Authors:  M A Dressman; I M Olivos-Glander; R L Nussbaum; S F Suchy
Journal:  J Histochem Cytochem       Date:  2000-02       Impact factor: 2.479

4.  Mapping of a gene (MRXS9) for X-linked mental retardation, microcephaly, and variably short stature to Xq12-q21.31.

Authors:  A E Shrimpton; K M Daly; J J Hoo
Journal:  Am J Med Genet       Date:  1999-05-28

5.  The deficiency of PIP2 5-phosphatase in Lowe syndrome affects actin polymerization.

Authors:  Sharon F Suchy; Robert L Nussbaum
Journal:  Am J Hum Genet       Date:  2002-11-11       Impact factor: 11.025

6.  Mice lacking renal chloride channel, CLC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis.

Authors:  S S Wang; O Devuyst; P J Courtoy; X T Wang; H Wang; Y Wang; R V Thakker; S Guggino; W B Guggino
Journal:  Hum Mol Genet       Date:  2000-12-12       Impact factor: 6.150

7.  Glomerular protein sieving and implications for renal failure in Fanconi syndrome.

Authors:  A G Norden; M Lapsley; P J Lee; C D Pusey; S J Scheinman; F W Tam; R V Thakker; R J Unwin; O Wrong
Journal:  Kidney Int       Date:  2001-11       Impact factor: 10.612

8.  Carrier assessment in families with lowe oculocerebrorenal syndrome: novel mutations in the OCRL1 gene and correlation of direct DNA diagnosis with ocular examination.

Authors:  W Röschinger; A C Muntau; G Rudolph; A A Roscher; S Kammerer
Journal:  Mol Genet Metab       Date:  2000-03       Impact factor: 4.797

9.  Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome.

Authors:  Rosa Vargas-Poussou; Chunfa Huang; Philippe Hulin; Pascal Houillier; Xavier Jeunemaître; Michel Paillard; Gabrielle Planelles; Michèle Déchaux; R Tyler Miller; Corinne Antignac
Journal:  J Am Soc Nephrol       Date:  2002-09       Impact factor: 10.121

10.  Loss of chloride channel ClC-5 impairs endocytosis by defective trafficking of megalin and cubilin in kidney proximal tubules.

Authors:  Erik I Christensen; Olivier Devuyst; Geneviève Dom; Rikke Nielsen; Patrick Van der Smissen; Pierre Verroust; Michèle Leruth; William B Guggino; Pierre J Courtoy
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-18       Impact factor: 12.779

View more
  121 in total

1.  Update on the genetics of nephrolithiasis.

Authors:  Giuseppe Vezzoli; Teresa Arcidiacono; Vera Paloschi; Annalisa Terranegra; Rita Biasion; Laura Soldati
Journal:  Clin Cases Miner Bone Metab       Date:  2008-05

2.  OCRL1 modulates cilia length in renal epithelial cells.

Authors:  Youssef Rbaibi; Shanshan Cui; Di Mo; Marcelo Carattino; Rajeev Rohatgi; Lisa M Satlin; Christina M Szalinski; Lisa M Swanhart; Heike Fölsch; Neil A Hukriede; Ora A Weisz
Journal:  Traffic       Date:  2012-07-04       Impact factor: 6.215

3.  Mouse model for Lowe syndrome/Dent Disease 2 renal tubulopathy.

Authors:  Susan P Bothwell; Emily Chan; Isa M Bernardini; Yien-Ming Kuo; William A Gahl; Robert L Nussbaum
Journal:  J Am Soc Nephrol       Date:  2010-12-23       Impact factor: 10.121

Review 4.  Chloride channel diseases resulting from impaired transepithelial transport or vesicular function.

Authors:  Thomas J Jentsch; Tanja Maritzen; Anselm A Zdebik
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

5.  A role of the Lowe syndrome protein OCRL in early steps of the endocytic pathway.

Authors:  Kai S Erdmann; Yuxin Mao; Heather J McCrea; Roberto Zoncu; Sangyoon Lee; Summer Paradise; Jan Modregger; Daniel Biemesderfer; Derek Toomre; Pietro De Camilli
Journal:  Dev Cell       Date:  2007-09       Impact factor: 12.270

6.  Novel OCRL mutations in Chinese children with Lowe syndrome.

Authors:  Yan-Qin Zhang; Fang Wang; Jie Ding; Hui Yan; Yan-Ling Yang
Journal:  World J Pediatr       Date:  2013-02-07       Impact factor: 2.764

7.  Characterization of 28 novel patients expands the mutational and phenotypic spectrum of Lowe syndrome.

Authors:  Florian Recker; Marcin Zaniew; Detlef Böckenhauer; Nunzia Miglietti; Arend Bökenkamp; Anna Moczulska; Anna Rogowska-Kalisz; Guido Laube; Valerie Said-Conti; Belde Kasap-Demir; Anna Niemirska; Mieczysław Litwin; Grzegorz Siteń; Krystyna H Chrzanowska; Małgorzata Krajewska-Walasek; Sidharth K Sethi; Velibor Tasic; Franca Anglani; Maria Addis; Anna Wasilewska; Maria Szczepańska; Krzysztof Pawlaczyk; Przemysław Sikora; Michael Ludwig
Journal:  Pediatr Nephrol       Date:  2014-12-06       Impact factor: 3.714

Review 8.  Dent disease: classification, heterogeneity and diagnosis.

Authors:  Yan-Yan Jin; Li-Min Huang; Xiao-Fang Quan; Jian-Hua Mao
Journal:  World J Pediatr       Date:  2020-04-04       Impact factor: 2.764

Review 9.  APPL1: role in adiponectin signaling and beyond.

Authors:  Sathyaseelan S Deepa; Lily Q Dong
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-10-14       Impact factor: 4.310

Review 10.  Physiological roles of CLC Cl(-)/H (+) exchangers in renal proximal tubules.

Authors:  Vanessa Plans; Gesa Rickheit; Thomas J Jentsch
Journal:  Pflugers Arch       Date:  2008-10-14       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.